RSSL
Global X Russell 2000 ETF
RSSL provides exposure to the Russell 2000 RIC Capped Index, which is comprised of up to 2000 small-cap U.S. listed equities as defined by FTSE Russell.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 1.4 B
ASSETS UNDER MGMT
8 bp
EXPENSES
Fund Basics
| Inception date | Jun 04, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| TWIST BIOSCIENCE CORP. | 0.4 % |
| MOOG INC-CLASS A | 0.4 % |
| UMB FINANCIAL CORP | 0.3 % |
| HUT 8 CORP | 0.3 % |
| 10X GENOMICS INC CLASS A | 0.3 % |
| JFROG LTD. | 0.3 % |
| BRIGHTSPRING HEALTH SERVICES, INC. | 0.3 % |
| VIASAT INC | 0.3 % |
| CARETRUST REIT INC | 0.3 % |
| BRINKER INTERNATIONAL INC | 0.3 % |
Constituent Breakdown
| Number of holdings | 1955 |
| Herfindahl-Hirschman Index | 12 |
| Wgt avg mkt cap (mns) | $3,939 |
| Large cap (>$10bn) | 3.2% |
| Mid cap ($2-10bn) | 69.5% |
| Small cap (<$2bn) | 26.6% |
| Developed mkts. | 100.2% |
| Emerging mkts. | 0.3% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 94.8 % |
 |
CANADA | 1.3 % |
 |
BERMUDA | 1.2 % |
 |
BRITAIN | 0.8 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 13.2% | 14.9% | 11.9% | -- | -- | -- | -- | 14.1% |
| Dividend Yield | 0.6% | 1.6% | 1.6% | -- | -- | -- | -- | 1.5% |
| Total Returns | 13.8% | 16.5% | 13.5% | -- | -- | -- | -- | 15.6% | Ann. Volatility | 18.2% | 18.7% | 21.4% | -- | -- | -- | -- | 21.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.18 | 67% |
| MSCI EAFE | 0.87 | 55% |
| MSCI Emg Mkts | 0.51 | 48% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.09% |
Technical Indicators
| 30d moving avg. (EMA) | $116.24 |
| Relative strength (RSI) | 60 |
| MACD/Signal | 1.02/0.69 |
| Bollinger Bands (Upper/Lower) | $119.91/$112.44 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. RSSL |
Expenses vs. RSSL |
ALTAR Score™ vs. RSSL |
|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 90.5% | +11 bp | -0.1% |
| VTWO | Vanguard Russell 2000 ETF | 89.7% | -1 bp | +0.0% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 58.8% | +1 bp | +1.0% |
| GSSC | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | 54.3% | +12 bp | +1.4% |
| IWN | iShares Russell 2000 Value ETF | 52.1% | +16 bp | +1.7% |
| VTWV | Vanguard Russell 2000 Value ETF | 52.0% | +2 bp | +1.8% |
| IWO | iShares Russell 2000 Growth ETF | 51.2% | +16 bp | -1.9% |
| VTWG | Vanguard Russell 2000 Growth ETF | 51.1% | +2 bp | -1.8% |
| STXK | Strive Small-Cap ETF | 50.7% | +10 bp | +2.7% |
| SCHA | Schwab U.S. Small-Cap ETF | 49.8% | -4 bp | +1.8% |
Risk and Returns: RSSL vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 10/2/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.3%
ALTAR SCORE™
16th
PERCENTILE
AVOID
ETFRC RATING
There are 1,398 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. RSSL's ALTAR Score™ is approximately -1.0 standard
deviations above the category average. This places RSSL in the 16th percentile
among funds in the category.
Sell-Side Consensus
$127.7
PRICE TARGET
+16.6%
UPSIDE